UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 384

Sortiert nach

How I treat relapsed acute lymphoblastic leukemia in the pediatric population

Blood, 2020-10, Vol.136 (16), p.1803-1812

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Journal of clinical oncology, 2020-06, Vol.38 (17), p.1897-1905

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232

Blood, 2015-08, Vol.126 (8), p.964-971

2015

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib reinduction chemotherapy in high‐risk ALL in first relapse: a report from the Children's Oncology Group

British journal of haematology, 2019-07, Vol.186 (2), p.274-285

2019

Link zum Volltext

Verfügbarkeit prüfen

Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia

Nature genetics, 2013-03, Vol.45 (3), p.290-294

2013

Link zum Volltext

Verfügbarkeit prüfen

FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631

Leukemia, 2021-05, Vol.35 (5), p.1279-1290

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk

Nature communications, 2019-11, Vol.10 (1), p.5348-9, Article 5348

2019

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia

Blood, 2012-05, Vol.119 (22), p.5201-5210

2012

Link zum Volltext

Verfügbarkeit prüfen

Intrachromosomal Amplification of Chromosome 21 Is Associated With Inferior Outcomes in Children With Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Risk Children's Oncology Group Studies: A Report From the Children's Oncology Group

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3397-3402

2013

Link zum Volltext

Verfügbarkeit prüfen

Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group

Journal of clinical oncology, 2017-08, Vol.35 (23), p.2700-2707

2017

Link zum Volltext

Verfügbarkeit prüfen

Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932

Leukemia, 2023-06, Vol.37 (6), p.1375-1378

2023

Link zum Volltext

Verfügbarkeit prüfen

Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331

Journal of clinical oncology, 2021-05, Vol.39 (14), p.1540-1552

2021

Link zum Volltext

Verfügbarkeit prüfen

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions

Cancers, 2021-04, Vol.13 (8), p.1847

2021

Link zum Volltext

Verfügbarkeit prüfen

Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations

Blood, 2021-03, Vol.137 (11), p.1550-1552

2021

Link zum Volltext

Verfügbarkeit prüfen

Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study

Journal of clinical oncology, 2008-08, Vol.26 (22), p.3756-3762

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside

1st ed. 2022., 2021

Link zum Volltext

Verfügbarkeit prüfen

T-cell acute lymphoblastic leukemia

Hematology, 2016-12, Vol.2016 (1), p.580-588

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Laboratory Biology of Childhood Acute Lymphoblastic Leukemia

The Journal of pediatrics, 2012, Vol.160 (1), p.10-18

2012

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia

Blood, 2008-11, Vol.112 (10), p.4178-4183

2008

Link zum Volltext

Verfügbarkeit prüfen

BUBR1 recruits PP2A via the B56 family of targeting subunits to promote chromosome congression

Biology open, 2013-05, Vol.2 (5), p.479-486

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-03, Vol.325 (9), p.833

2021

Link zum Volltext

Verfügbarkeit prüfen

Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis--case report and review of the literature

The American journal of surgical pathology, 2012-01, Vol.36 (1), p.149-153

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 384

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(368)
Mit Volltextzugriff
(362)

Publikationsform

Sprache

Englisch
(384)
Japanisch
(33)
Polnisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(174)
Life Sciences & Biomedicine
(172)
Humans
(161)
Child
(134)
Oncology
(105)
Hematology
(99)
Male
(87)
Female
(83)
Child, Preschool
(72)
Adolescent
(70)
Pediatrics
(59)
Acute Lymphoblastic Leukemia
(55)
Infant
(52)
Leukemia
(48)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(45)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Genetics
(42)
Adult
(39)
Children
(33)
Disease-Free Survival
(31)
Prognosis
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(150)
Journal Of Clinical Oncology
(68)
Pediatric Blood & Cancer
(30)
Leukemia
(12)
Haematologica
(8)
Cancer
(7)
Cancer Research
(6)
Jnci : Journal Of The National Cancer Institute
(5)
Journal Of Pediatric Hematology/oncology
(5)
British Journal Of Haematology
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

How I treat relapsed acute lymphoblastic leukemia in the pediatric population

Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232

Bortezomib reinduction chemotherapy in high‐risk ALL in first relapse: a report from the Children's Oncology Group

Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia

FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631

Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk

Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia

Intrachromosomal Amplification of Chromosome 21 Is Associated With Inferior Outcomes in Children With Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Risk Children's Oncology Group Studies: A Report From the Children's Oncology Group

Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232

Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group

Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932

Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions

Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations

Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study

Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside

T-cell acute lymphoblastic leukemia

Clinical and Laboratory Biology of Childhood Acute Lymphoblastic Leukemia

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia

BUBR1 recruits PP2A via the B56 family of targeting subunits to promote chromosome congression

Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial

Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis--case report and review of the literature

Suchergebnisse filtern